%0 Journal Article
%T Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey
%A Claudio Rigatto
%A David Collister
%A David Conen
%A Jeff S. Healey
%A K. Scott Brimble
%A Manish M. Sood
%A Michael Walsh
%A Ziv Harel
%J Archive of "Canadian Journal of Kidney Health and Disease".
%D 2019
%R 10.1177/2054358118821945
%X Nonvalvular atrial fibrillation (NVAF) is an independent risk factor for ischemic stroke and is common in chronic kidney disease (CKD) and dialysis patients. The use of oral anticoagulation to prevent stroke and systemic embolism in the setting of kidney disease is controversial. Novel alternatives to vitamin K antagonists include left atrial appendage occlusion devices (LAAOD) and apixaban
%K atrial fibrillation
%K dialysis
%K stroke
%K prevention
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327328/